Frequent Good News! Xingyue Biotechnology Wins the "AI + Healthcare Smart Benchmark Award"
On March 18th, the "AI + Healthcare" Innovation and Development Conference & the 2025 Annual Meeting of the Yuhang District (Hangzhou) Biomedical Industry Association was successfully held. At the conference, Xingyue Biotechnology Co., Ltd. was awarded the prestigious "AI + Healthcare Smart Benchmark Award" in recognition of its capabilities in scientific research and translation within the field of regenerative medicine. Mr. Zhao Hongshi, the General Manager of the company, attended the conference to receive the award.
Currently, with the in-depth implementation of the "Healthy China 2030" strategy, the deep integration of biomedicine and artificial intelligence has become a core engine for cultivating new quality productive forces and promoting the high-quality development of the life and health industry. Themed "Digital Intelligence Opens the Future, Healthcare Enterprises Embark on a New Journey," this conference focused on the cutting-edge trends and practical implementation of "AI + Healthcare." It brought together representatives from medical device companies, pharmaceutical companies, research institutes, and other parties to jointly assess the future trends of the deep integration of AI and healthcare, creating an industry platform for high-level exchanges, cooperation, and the sharing of achievements.
As a key innovator in Yuhang District's life and health industry, Xingyue Biotechnology consistently prioritizes both original innovation and systematic planning, actively exploring multi-scenario applications of the "silk fibroin +" platform. The company not only focuses on products for sports medicine and regenerative medicine but also delves deeply into efficacy skincare and medical aesthetics products. With the integration and upgrading of "traditional materials + cutting-edge technology" as its main thread, Xingyue has successfully achieved a value leap "from textile to medical treatment," driving industrial value addition.
Leveraging the regional innovation ecosystem and policy support, Xingyue Biotechnology has achieved large-scale production of medical-grade silk fibroin, establishing an entire industrial chain from raw material base to end products. While strengthening core technology accumulation, the company actively explores how to utilize digital and intelligent means to optimize production processes and enhance R&D efficiency and product quality. By constructing a precise and efficient production control system, Xingyue has effectively solved the problem of batch-to-batch instability encountered during industrial scaling, significantly shortening the translation period for silk-based medical materials from the laboratory to clinical application. This has accelerated the R&D process for Class III medical devices used in trauma repair and tissue regeneration, providing a solid foundation for the deep implementation of "AI + Healthcare" in the materials field.
From technological breakthroughs to industrial practice, Xingyue Biotechnology has opened up the key links from basic research to product translation, continuously propelling high-end medical devices towards greater intelligence, precision, and internationalization. Winning the "AI + Healthcare Smart Benchmark Award" is another important recognition for the company, following its accolades as an "Advanced Unit for Scientific and Technological Innovation in Yuhang District" and a "Model Enterprise for Talent Innovation and Entrepreneurship." It fully reflects the industry's high regard for Xingyue's innovative practices and underscores the company's proactive role in driving innovation-led development within the life and health sector.
Looking ahead, Xingyue Biotechnology will continue to deepen the integration of industry, academia, research, and application, expanding the cross-disciplinary application of intelligent technology and regenerative medicine, and helping China's high-end biomedical materials advance towards a new stage of higher-quality development.
